Dr. Xenofon Baraliakos presents the MAXIMISE trial which showed improvement in axial involvement in PsA patients treated with secukinumab. Abstract OPO235 #EULAR2019 @RheumNow #spondylitis #Novartis https://t.co/exxbgIxgJT